Topic: Sanofi-Aventis SA

Study Finds Higher Education Predicts Better Cardiovascular Health Outcomes In High-Income Countries, But Not In Low- And Middle-Income

Medical News Today - 4 hours ago
In one of the first international studies to compare the link between formal education and heart disease and stroke, the incidence of these...

Pfizer, American Kennel Club reach deal

AP Features - 11 hours ago
Pfizer Inc. said Wednesday its animal health unit and the American Kennel Club Canine Health Foundation entered an exclusive partnership on new areas of research on dog diseases and treatments.Pfizer said the goal is to strengthen efforts to prevent, trea

Sanofi pitched $71 offer to Genzyme: report

Reuters US Online Report Business News - 16 hours ago
BOSTON (Reuters) - Sanofi-Aventis SA pitched a new offer to acquire U.S. biotechnology company Genzyme Corp for $71 a share in exchange for the opportunity to conduct "partial due diligence," according to DealReporter, which cited a source close to the

Sanofi Pitched $71 Offer to Genzyme: Report

ABC News - 19 hours ago
Sanofi-Aventis SA pitched a new offer to acquire U.S. biotechnology company Genzyme Corp for $71 a share in exchange for the opportunity to conduct ...

S&P May Pare Credit Ratings On Sanofi-Aventis

Drugs.com - 20 hours ago
Standard & Poor's Ratings Services may cut its credit ratings on Sanofi-Aventis, which is trying to buy the biotechnology company Genzyme.. . The ...

Sanofi C.E.O. Talks to Genzyme Investors

New York Times - yesterday
Sanofi-Aventis's chief executive, Chris Viehbacher, took his case for a takeover directly to Genzyme's investors in meetings in New York on...

Sanofi’s CEO Pitches Genzyme Investors on Takeover

Businessweek - yesterday
By Jacqueline Simmons, Jeffrey McCracken and Elizabeth Lopatto . Sept. 8 (Bloomberg) -- Sanofi-Aventis SA's Chief Executive Officer Chris...

STOCKS NEWS EUROPE-Shares edge up in early trade

Reuters, UK - yesterday
European shares inch higher in early trade as a rise in defensive stocks such as pharmaceuticals and utilities rise, while banks fall on renewed...

Genzyme CEO open to sale, not at $69 a share

Reuters US Online Report Business News - 7 days ago
BOSTON (Reuters) - Genzyme Corp Chief Executive Henri Termeer said he is willing to sell the company he built up over 25 years, but not for $69 a share.In an interview with Reuters, Termeer said it was unlikely that French drugmaker Sanofi-Aventis ...

Hostile Bid in the Works for Genzyme Corp (NASDAQ: GENZ), Citigroup, Inc (NYSE: C) Says

American Banking News - 36 days ago
Citigroup, Inc (NYSE: C) analysts said in a research note that Sanofi-Aventis SA may begin a hostile bid for Genzyme Corp (NASDAQ: GENZ) if the...